FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date. 

Government

• Special district governments
• City or township governments
• Public and Indian housing authorities
• Federally recognized Native American tribal governments
• State governments
• County governments

Nonprofit

• Other Native American tribal organizations
• Nonprofits non-higher education without 501(c)(3)
• Nonprofits non-higher education with 501(c)(3)

Business

• For-profit organizations other than small businesses
• Small businesses

Education

• Independent school districts
• Public and state institutions of higher education
• Private institutions of higher education